5-EAPB powder also referred to as 1-(benzofuran-5-yl)-N-ethylpropan-2-amine is an N-ethyl comparison of 5-APB as well as being structurally related to 5-MAPB. The chemical compound is also known to be an entactogenic amphetamine. With its relationship to the above compounds it is thought be agonists of the 5-HT2C receptor along with being a triple monoamine reuptake inhibitors.
CAS: 1445566-01-7
Formula: C13H17NO
Purity: 99,7% min
Molecular weight: 239.78
Appearance: Need to clarify
5-EAPB (1-(benzofuran-5-yl)-N-ethylpropan-2-amine) is an entactogenic amphetamine which is structurally related to 5-MAPB and 5-APB. It might be predicted to show similar effects to these drugs in humans, but the pharmacology of 5-EAPB remains unstudied as of 2013.
5-EAPB is similar in structure to compounds such as 5-APB which are claimed to be agonists of the 5-HT2C receptor as well as a triple monoamine reuptake inhibitors, however 5-EAPB is not listed as an example in this patent, and it is not yet established to what extent the activity of 5-EAPB resembles that of 5-APB.
As an N-ethyl derivative of 5-APB, 5-EAPB falls outside the scope of the Temporary Class Drug ban issued by the Home Office on June 10, 2013, and remains uncontrolled in the UK as of November 2013. The ACMD has advised that 5-EAPB (and other -APBs) are moved to Class B, this will likely come into action on 10 June 2014.
5-EAPB also referred to as 1-(benzofuran-5-yl)-N-ethylpropan-2-amine is an N-ethyl comparison of 5-APB as well as being structurally related to 5-MAPB. The chemical compound is also known to be an entactogenic amphetamine. With its relationship to the above compounds it is thought be agonists of the 5-HT2C receptor along with being a triple monoamine reuptake inhibitors.
5-EAPB is similar in structure to compounds such as 5-APB which are claimed to be agonists of the 5-HT2C receptor as well as a triple monoamine reuptake inhibitors, however 5-EAPB is not listed as an example in this patent, and it is not yet established to what extent the activity of 5-EAPB resembles that of 5-APB.
As an N-ethyl derivative of 5-APB, 5-EAPB falls outside the scope of the Temporary Class Drug ban issued by the Home Office on June 10, 2013, and remains uncontrolled in the UK as of November 2013. The ACMD has advised that 5-EAPB (and other -APBs) are moved to Class B, this will likely come into action on 10 June 2014.
